AlphAIAlphAI — Financial news for AI agents
tradingview.comOCT 201 min read$NAUT

NAUT Q3'26 Earnings: revenue estimate is 206.25K USD

Nautilus Biotechnology (NAUT) will report Q3'26 earnings on October 27. Analysts expect revenue of $206.25K and a loss of $0.14 per share. The announcement is scheduled for 9:30 AM ET.

Original reporting
tradingview.com
Published Oct 20, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 11:08 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
NAUT Q3'26 Earnings: revenue estimate is 206.25K USD — source image
Source · tradingview.com
Decision brief

The 30-second read

$NAUTBearishLow
01

Why it matters

The earnings estimate is the first disclosed guidance for Q3'26, offering a baseline for traders.

02

Market read

Provides a fresh data point for NAUT; limited broader market relevance.

03

What to watch

Potential upcoming clinical trial data or partnership announcements not reflected in the estimate.

Relevance 5/10Novelty 4/10Timing: pre‑market on Oct 27

Background

Nautilus Biotechnology is a micro‑cap biotech listed on NASDAQ under NAUT.

Company-level read

Ticker impact

$NAUTBearishMedium confidence
Context

Article provides the first public revenue and EPS estimates for NAUT's Q3'26 earnings, a primary earnings disclosure.

Expected impact

likely downside as market prices in the modest guidance

Evidence & confidence

Micro‑cap biotech with $206k revenue forecast signals weak near‑term performance.

Market effects

Sector

Minimal impact on biotech sector; guidance reflects typical early‑stage revenue patterns.

Regional

Negligible effect on broader US market.

Global

Limited to investors tracking micro‑cap biotech stocks.

Counterpoint

What could challenge this read

If the company secures a breakthrough partnership, the guidance could be a floor rather than a ceiling.

Key entities

  • Company
    Nautilus Biotechnology, Inc.

    US‑listed biotech firm reporting Q3'26 guidance.

Read at source← All news

Related articles

OCT 26
$NAUTLow

Nautilus Biotechnology Reports Third Quarter 2026 Financial Results

Nautilus Biotechnology, Inc. (NAUT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Nautilus Biotechnology Reports Third Quarter 2026 Financial Results SEATTLE, WA, October 27, 2026 – Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third quarter

SEC EDGAR 8-K2 min
JUL 27
$NAUTMed

Nautilus Biotechnology Reports Second Quarter 2026 Financial Results

Nautilus Biotechnology, Inc. (NAUT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991-q2268xkearnings.htm EX-99.1 Document Exhibit 99.1 Nautilus Biotechnology Reports Second Quarter 2026 Financial Results SEATTLE, WA, July 28, 2026 – Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform,

SEC EDGAR 8-K6 min
OCT 27
$VFCHigh

VF Corporation faces earnings test as Vans turnaround hangs in balance

VF Corporation (VFC) reports Q2 2027 earnings on Wednesday, with investors focused on the Vans brand's recovery. The company expects $0.53 EPS on $2.66B revenue, a turnaround from last quarter's loss. Analysts expect a 5% revenue decline but watch for signs of sequential improvement and guidance updates. VFC's stock has risen 30% from September lows, with a consensus price target of $18.96.

investing.com2 min
OCT 27
$HLTHighAI 8/10

Hilton Worldwide 3Q 2026: Revenue $3.33B, EPS $2.37— 10-Q Summary

Hilton Worldwide reported 3Q 2026 revenue of $3.33B, up 6.6% YoY, and net income of $536M, up 27.6% YoY. EPS was $2.37. The company opened 520 hotels and added 55,500 net rooms in the first nine months. Systemwide RevPAR rose 5.8%, with U.S. RevPAR up 7.0% and Europe up 6.5%. Hilton Honors membership grew 15% YoY to 270 million. The company noted potential delays in hotel openings due to inflation and interest rates.

tradingview.com1 min